All Articles

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

Nullify lands $12.5M to deploy autonomous AI security engineers, aiming to solve the cyber talent gap by replacing manual work with merge-ready code.

WealthTech firm BizEquity targets the Great Wealth Transfer with a new brand and AI-powered platform to help advisors value and plan for business owner clients.

Main Street Capital and Iron Creek Partners facilitate a buyout of BASELoad, LLC, a key player in healthcare data, signaling a strategic push into this vital sector.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

Everbright Digital hopes a 1-for-16 reverse stock split will save its Nasdaq listing, but the move raises questions about its metaverse-focused future.

A new contract gives Canadian municipalities streamlined access to robotic mowers, a high-tech solution for labor shortages and budget pressures.

Pilot Fiber's acquisition of Extenet's enterprise fiber business expands its reach into NJ, targeting the high-stakes finance and AI sectors.

As Melco Resorts prepares its 2025 results, investors watch for signs of Macau's sustained recovery and the payoff from its bold global expansion.

A new study reveals Exicure's burixafor mobilizes stem cells in one hour, promising to streamline cancer treatment and unlock future gene therapies.

For its tenth straight Games, Technogym will equip Milano Cortina 2026 with AI-driven gear, cementing its legacy as the force behind athletic excellence.

The multiyear agreement makes Baker Hughes the preferred tech provider for Marathon's vast network of oil and renewable fuels facilities across North America.

As open finance regulations loom and sophisticated fraud surges, a new partnership aims to build trust and security into the core of financial data sharing.

Kinaxis's new Maestro Agent Studio lets supply chain teams build their own AI assistants without code, aiming to revolutionize real-time decision-making.

New data reveals an AI-powered system can map and guide heart arrhythmia treatment in minutes with zero fluoroscopy, heralding a new era of safety and speed.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

The investment giant posted a record $129 billion in annual fundraising, but a slight miss on quarterly earnings sent its stock tumbling.

VectorY Therapeutics adds seasoned biotech architect Kevin Pojasek to its board, signaling a strategic push to accelerate its novel therapies for ALS and Alzheimer's.

As it enters its tenth year, the Zephyr RTOS adds Schneider Electric and others, signaling a major push for standardization and security in a regulated IoT world.

Insulet launches its tubeless Omnipod 5 insulin pump and new Discover data platform in the Middle East, offering a new lifeline for a region in need.